Mallinckrodt (MNK), Daiichi Said to Consider Bids for Depomed (DEPO) - Bloomberg

November 3, 2016 6:33 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Mallinckrodt (NYSE: MNK) and Daiichi are mulling bids for Depomed (NASDAQ: DEPO), according to Bloomberg, citing people familiar. Shionogi may also be interested in a bid or partnerships, the report said, and Depomed could also attract interest from private equity firms.

The sale process is in the second round and a buyer may be chosen as early as year-end.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Private Equity, Rumors

Add Your Comment